Vitamin E and Age-Related Macular Degeneration in a Randomized Trial of Women

Ophthalmology

Volumn 117, Issue 6, 2010, Pages 1163-1168

  Christen, William G ^a   Glynn, Robert J ^a,b   Chew, Emily Y ^d   Buring, Julie E ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; MULTIVITAMIN; PLACEBO;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; LOW DRUG DOSE; MENOPAUSE; NEOPLASM; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; SELF REPORT; VISUAL ACUITY; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION;

AGED; ANTIOXIDANTS; BODY MASS INDEX; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MACULAR DEGENERATION; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; VISUAL ACUITY; VITAMIN E; WOMEN'S HEALTH;

EID: 77952890898     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.10.043     Document Type: Article

References (38)

1. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
2. Klein R., Wang Q., Klein B.E., et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 36 (1995) 182-191
3. Hogg R.E., and Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res 25 (2006) 249-276
4. Klein R., Klein B.E., Tomany S.C., et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 109 (2002) 1767-1779
5. Age-Related Eye Disease Study Research Group. A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch Ophthalmol 123 (2005) 1570-1574
6. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five-year results from randomized clinical trials. Arch Ophthalmol 109 (1991) 1109-1114
7. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol 111 (1993) 1200-1209
8. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 119 (2001) 198-207
9. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol 131 (2001) 541-560
10. Gragoudas E.S., Adamis A.P., Cunningham Jr. E.T., et al., VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
11. Rosenfeld P.J., Brown D.M., Heier J.S., et al., MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
12. Michels S., Rosenfeld P.J., Puliafito C.A., et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112 (2005) 1035-1047
13. Winkler B.S., Boulton M.E., Gottsch J.D., and Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis 5 (1999) 32-42. http://www.molvis.org/molvis/v5/a32/ Accessed October 25, 2009
14. Coleman H., and Chew E. Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol 18 (2007) 220-223
15. Chiu C.J., and Taylor A. Nutritional antioxidants and age-related cataract and maculopathy. Exp Eye Res 84 (2007) 229-245
16. Mares-Perlman J.A., Klein R., Klein B.E., et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 114 (1996) 991-997
17. VandenLangenberg G.M., Mares-Perlman J.A., Klein R., et al. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 148 (1998) 204-214
18. van Leeuwen R., Boekhoorn S., Vingerling J.R., et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 294 (2005) 3101-3107
19. Cho E., Seddon J.M., Rosner B., et al. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 122 (2004) 883-892
20. Klein B.E., Knudtson M.D., Lee K.E., et al. Supplements and age-related eye conditions: the Beaver Dam Eye Study. Ophthalmology 115 (2008) 1203-1208
21. Tan J.S., Wang J.J., Flood V., et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 115 (2008) 334-341
22. Age-Related Eye Disease Study Research Group. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report no. 22. Arch Ophthalmol 125 (2007) 1225-1232
23. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119 (2001) 1417-1436
24. Teikari J.M., Laatikainen L., Virtamo J., et al. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand 76 (1998) 224-229
25. Taylor H.R., Tikellis G., Robman L.D., et al. Vitamin E supplementation and macular degeneration: randomised controlled trial. [report online]. BMJ (2002). http://www.bmj.com/cgi/reprint/325/7354/11 Accessed October 25, 2009
26. Christen W.G., Manson J.E., Glynn R.J., et al. Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians. Arch Ophthalmol 125 (2007) 333-339
27. Evans J.R., and Henshaw K. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev 1 (2008) CD000253
28. Klein R., Klein B.E., Linton K.L., and DeMets D.L. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 137 (1993) 190-200
29. Christen W.G., Glynn R.J., Manson J.E., et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 276 (1996) 1147-1151
30. Seddon J.M., Willett W.C., Speizer F.E., and Hankinson S.E. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 276 (1996) 1141-1146
31. Lee I.M., Cook N.R., Gaziano J.M., et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 294 (2005) 56-65
32. Cook N.R., Lee I.M., Gaziano J.M., et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294 (2005) 47-55
33. Ridker P.M., Cook N.R., Lee I.M., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352 (2005) 1293-1304
34. Glynn R.J., Ridker P.M., Goldhaber S.Z., et al. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation 116 (2007) 1497-1503
35. Lee I.M., Cook N.R., Manson J.E., et al. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 91 (1999) 2102-2106
36. Christen W., Glynn R., Sperduto R., et al. Age-related cataract in a randomized trial of beta-carotene in women. Ophthalmic Epidemiol 11 (2004) 401-412
37. Cox D.R. Regression models and life-tables. J R Stat Soc Ser B 34 (1972) 187-220
38. Chong E.W., Wong T.Y., Kreis A.J., et al. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ 335 (2007) 755. http://www.bmj.com/cgi/reprint/335/7623/755 Accessed October 25, 2009